|
CDH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.66019999999967E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.983300E-04 |
| Normal-vs-Stage2 |
1.128010E-02 |
| Normal-vs-Stage3 |
2.18009999999325E-05 |
| Normal-vs-Stage4 |
2.06670000002518E-07 |
| Stage1-vs-Stage2 |
9.821800E-01 |
| Stage1-vs-Stage3 |
1.080450E-01 |
| Stage1-vs-Stage4 |
4.039800E-03 |
| Stage2-vs-Stage3 |
3.204000E-01 |
| Stage2-vs-Stage4 |
7.881700E-02 |
| Stage3-vs-Stage4 |
2.496200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.422100E-04 |
| Normal-vs-AfricanAmerican |
1.284410E-02 |
| Normal-vs-Asian |
4.33069999999924E-05 |
| Caucasian-vs-AfricanAmerican |
7.573600E-01 |
| Caucasian-vs-Asian |
2.056200E-01 |
| AfricanAmerican-vs-Asian |
6.158600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.415200E-04 |
| Normal-vs-Female |
2.25479999999001E-05 |
| Male-vs-Female |
8.709400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.280190E-03 |
| Normal-vs-Age(41-60Yrs) |
1.982050E-04 |
| Normal-vs-Age(61-80Yrs) |
2.20190000010945E-07 |
| Normal-vs-Age(81-100Yrs) |
2.750000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.422400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.517540E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.347000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.784200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.676000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.791600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.935900E-03 |
| Classical-VS-Follicular |
5.025400E-04 |
| Classical-VS-Other |
9.135400E-01 |
| Classical-VS-Normal |
1.935930E-03 |
| Tall-VS-Follicular |
6.920800E-01 |
| Tall-VS-Other |
4.707600E-01 |
| Tall-VS-Normal |
3.52230000000286E-06 |
| Follicular-VS-Other |
3.193600E-01 |
| Follicular-VS-Normal |
4.59779999961718E-07 |
| Other-VS-Normal |
1.807430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.166400E-04 |
| Normal-vs-N1 |
1.67819999996599E-06 |
| N0-vs-N1 |
9.383700E-02 |
|
|
